BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25704429)

  • 21. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
    Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H
    Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival impact of postoperative body mass index in gastric cancer patients undergoing gastrectomy.
    Lee HH; Park JM; Song KY; Choi MG; Park CH
    Eur J Cancer; 2016 Jan; 52():129-37. PubMed ID: 26686912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.
    Dikken JL; Jansen EP; Cats A; Bakker B; Hartgrink HH; Kranenbarg EM; Boot H; Putter H; Peeters KC; van de Velde CJ; Verheij M
    J Clin Oncol; 2010 May; 28(14):2430-6. PubMed ID: 20368551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncologic Effectiveness and Safety of Bursectomy in Patients with Advanced Gastric Cancer: A Systematic Review and Updated Meta-Analysis.
    Marano L; Polom K; Bartoli A; Spaziani A; De Luca R; Lorenzon L; Di Martino N; Marrelli D; Roviello F; Castagnoli G
    J Invest Surg; 2018 Dec; 31(6):529-538. PubMed ID: 28972457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy.
    Chen S; Feng XY; Li YF; Zhao BW; Zhou ZW; Chen YB
    J Surg Oncol; 2013 May; 107(6):641-5. PubMed ID: 23297055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Five-year follow-up of a randomized clinical trial comparing bursectomy and omentectomy alone for resectable gastric cancer (JCOG1001).
    Kurokawa Y; Doki Y; Mizusawa J; Yoshikawa T; Yamada T; Kimura Y; Takiguchi S; Nishida Y; Fukushima N; Cho H; Kaji M; Hirao M; Sasako M; Terashima M
    Br J Surg; 2022 Dec; 110(1):50-56. PubMed ID: 36369984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficiency of bursectomy in patients with resectable gastric cancer: An updated meta-analysis.
    Xiong B; Ma L; Huang W; Cheng Y; Luo H; Wang K
    Eur J Surg Oncol; 2019 Aug; 45(8):1483-1492. PubMed ID: 30691723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis.
    Jiang L; Yang KH; Guan QL; Zhao P; Chen Y; Tian JH
    J Surg Oncol; 2013 Jun; 107(8):807-14. PubMed ID: 23512524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should elderly patients undergo additional surgery after non-curative endoscopic resection for early gastric cancer? Long-term comparative outcomes.
    Kusano C; Iwasaki M; Kaltenbach T; Conlin A; Oda I; Gotoda T
    Am J Gastroenterol; 2011 Jun; 106(6):1064-9. PubMed ID: 21407189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BURSECTOMY IN GASTRIC CANCER SURGERY: A META-ANALYSIS.
    Li Y; Li Y; Wang K
    Rev Invest Clin; 2019; 71(2):98-105. PubMed ID: 31056612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer.
    Cai J; Wei D; Gao CF; Zhang CS; Zhang H; Zhao T
    Dig Surg; 2011; 28(5-6):331-7. PubMed ID: 21934308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of the proximal margin frozen section for resection of gastric adenocarcinoma: a 7-Institution Study of the US Gastric Cancer Collaborative.
    Squires MH; Kooby DA; Pawlik TM; Weber SM; Poultsides G; Schmidt C; Votanopoulos K; Fields RC; Ejaz A; Acher AW; Worhunsky DJ; Saunders N; Jin LX; Levine E; Cho CS; Bloomston M; Winslow E; Cardona K; Staley CA; Maithel SK
    Ann Surg Oncol; 2014 Dec; 21(13):4202-10. PubMed ID: 25047464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncologic outcomes of laparoscopy-assisted distal gastrectomy for gastric cancer.
    Fukunaga T; Hiki N; Kubota T; Nunobe S; Tokunaga M; Nohara K; Sano T; Yamaguchi T
    Ann Surg Oncol; 2013 Aug; 20(8):2676-82. PubMed ID: 23709054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perioperative chemotherapy for resectable gastroesophageal cancer: a single-center experience.
    Molina R; Lamarca A; Martínez-Amores B; Gutiérrez A; Blázquez A; López A; Granell J; Álvarez-Mon M
    Eur J Surg Oncol; 2013 Aug; 39(8):814-22. PubMed ID: 23755989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
    Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
    Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changing pattern of postoperative body weight and its association with recurrence and survival after curative resection for gastric cancer.
    Lee SE; Lee JH; Ryu KW; Nam B; Kim CG; Park SR; Kook MC; Kim YW
    Hepatogastroenterology; 2012; 59(114):430-5. PubMed ID: 22353511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative outcomes and complications after laparoscopy-assisted pylorus-preserving gastrectomy for early gastric cancer.
    Jiang X; Hiki N; Nunobe S; Fukunaga T; Kumagai K; Nohara K; Sano T; Yamaguchi T
    Ann Surg; 2011 May; 253(5):928-33. PubMed ID: 21358534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A reliable risk score for stage IV esophagogastric cancer.
    Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
    Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.